BiotechTube

Testim 1% (testosterone gel) + Placebo

Phase 2Terminated
0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Jul 1, 2005 → Jan 1, 2007

NCT ID
NCT00254553

About Testim 1% (testosterone gel) + Placebo

Testim 1% (testosterone gel) + Placebo is a phase 2 stage product being developed by Merck for Hypogonadism. The current trial status is terminated. This product is registered under clinical trial identifier NCT00254553. Target conditions include Hypogonadism.

What happened to similar drugs?

6 of 19 similar drugs in Hypogonadism were approved

Approved (6) Terminated (3) Active (12)
✅Topical Testosterone SolutionEli LillyApproved
✅AndroGel® + PlaceboAbbVieApproved
✅AndroGel 1.62%AbbVieApproved
✅Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
✅NEBIDO + PLACEBOBayerApproved
✅JatenzoICON plc.Approved
🔄Testosterone Solution + Placebo SolutionEli LillyPhase 3

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00254553Phase 2Terminated

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
43
Testosterone Solution + Placebo SolutionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 2
35
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
29
ABT-SLV176AbbViePhase 3
32
AndroGel® + PlaceboAbbVieApproved
43
AndroGel 1.62%AbbVieApproved
43
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
40
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
35
Reference: Follitropin alfa + ZoladexMerckPhase 1
29
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
27
Testosterone Enanthate + FinasterideMerckPhase 2
35
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Test formulation + Reference formulationPfizerPhase 1
29
Testosterone ProductBayerPre-clinical
23
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
37
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
23
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
32